Bio-Path Holdings Inc Sample Contracts

Exhibit 1.2 Form SB-2 Ogden Golf Co. Corporation ESCROW AGREEMENT This ESCROW AGREEMENT ("Agreement"), made and entered into as of __________, 2002, by and among ACAP FINANCIAL, INC., a Utah corporation (the "Underwriter"), Ogden Golf Co. Corporation,...
Escrow Agreement • May 8th, 2003 • Ogden Golf Co Corp • Utah
Sample 1Sample 2Sample 3See All (1k)
AutoNDA by SimpleDocs
COMMON STOCK PURCHASE WARRANT bio-path holdings, inc.
Bio-Path Holdings Inc • March 26th, 2024 • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [______________]1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (1k)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 22nd, 2019 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of November 21, 2019, between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Sample 1Sample 2Sample 3See All (1k)
Exhibit 1.1 Form SB-2 Ogden Golf Co. Corporation OGDEN GOLF CO. CORPORATION 1782 Washington Boulevard Ogden, UT 84404 UNDERWRITING AGREEMENT March __, 2003 ACAP Financial, Inc. 47 West 200 South, Suite 101 Salt Lake City, Utah 84101 Gentlemen: Ogden...
Ogden Golf Co Corp • May 8th, 2003 • Utah
Sample 1Sample 2Sample 3See All (925)
Bio-Path Holdings, Inc. 8,592,308 Shares of Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreement • January 16th, 2019 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York

Bio-Path Holdings, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 8,592,308 shares of its common stock, par value $0.001 per share (the “Shares”). The 8,592,308 Shares to be sold by the Company are called the “Offered Shares.” H.C. Wainwright & Co., LLC (“Wainwright”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriters listed on Schedule A, the term “Representative” as used herein shall mean you, as Underwriter, and the term “Underwriters” shall mean either the singular or the plural, as the context requires.

Sample 1Sample 2Sample 3See All (631)
COMMON STOCK PURCHASE WARRANT bio-path holdings, inc.
Common Stock Purchase Warrant • April 2nd, 2018 • Bio-Path Holdings Inc • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”), dated as of November 6, 2017, certifies that, for value received, Roth Capital Partners, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 6, 2018 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 3, 2022 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), up to 160,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (498)
COMMON STOCK PURCHASE WARRANT BIO-PATH HOLDINGS, INC.
Bio-Path Holdings Inc • June 4th, 2010 • Retail-miscellaneous shopping goods stores

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Lincoln Park Capital Fund, LLC (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 2, 2011 (the “Initial Exercise Date”) and on or prior to the close of business on the second anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BIO-PATH HOLDINGS, INC., a Utah corporation (the “Company”), up to 571,429 shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (491)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 19th, 2024 • Bio-Path Holdings, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 18, 2024, between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Sample 1Sample 2Sample 3See All (485)
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • June 4th, 2010 • Bio-Path Holdings Inc • Retail-miscellaneous shopping goods stores • Utah

REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of June 2, 2010, by and between BIO-PATH HOLDINGS, INC., a Utah corporation, (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").

Sample 1Sample 2Sample 3See All (387)
Exhibit 10.2 Form SB-2 Ogden Golf Co. Corporation BUSINESS LOAN AGREEMENT
Business Loan Agreement • August 6th, 2003 • Ogden Golf Co Corp • Sporting & athletic goods, nec • Utah
Sample 1Sample 2Sample 3See All (355)
Bio-Path Holdings, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • June 25th, 2015 • Bio-Path Holdings Inc • Retail-miscellaneous shopping goods stores • New York

Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

Sample 1Sample 2Sample 3See All (329)
BIO-PATH HOLDINGS, INC. and EQUINITI TRUST COMPANY, LLC, as Warrant Agent Warrant Agency Agreement Dated as of [●] WARRANT AGENCY AGREEMENT
Warrant Agency Agreement • January 23rd, 2024 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York

WARRANT AGENCY AGREEMENT, dated as of [●] (“Agreement”), between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and Equiniti Trust Company, LLC, a New York limited liability trust company (the “Warrant Agent”).

Sample 1Sample 2Sample 3See All (246)
PLACEMENT AGENCY AGREEMENT
Placement Agency Agreement • January 23rd, 2024 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (173)
Borrower: Ogden Golf Co. Corporation Lender: Barnes Banking Company (TIN: 87-0652870) South Ogden 1781 Washington Blvd. 1840 East Skyline Drive Ogden, UT 84401 South Ogden, UT 84403 ===================================================...
Ogden Golf Co Corp • August 6th, 2003 • Sporting & athletic goods, nec

PROMISE TO PAY. OGDEN GOLF CO. CORPORATION ("Borrower") promises to pay to BARNES BANKING COMPANY ("Lender"), or order, in lawful money of the United States of America, the principal amount of One Hundred Thirty-Nine Thousand Five Hundred Thirty-Nine & 02/l00 Dollars ($139,539.02), together with interest on the unpaid principal balance from September 20, 2000, until paid in full. The interest rate will not increase above 18.000%.

Sample 1Sample 2Sample 3See All (165)
COMMON STOCK PURCHASE WARRANT BIO-PATH HOLDINGS, INC.
Common Stock Purchase • January 23rd, 2024 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [ ], 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), up to [____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to elect to

Sample 1Sample 2Sample 3See All (152)
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT bio-path holdings, inc.
Bio-Path Holdings, Inc. • April 19th, 2024 • Pharmaceutical preparations

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 18, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Engagement Agreement by and between the Company and H.C. Wainwright & Co., LLC, dated as of March 22, 2024.

Sample 1Sample 2Sample 3See All (139)
AT THE MARKET OFFERING AGREEMENT
Market Offering Agreement • July 14th, 2020 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (120)
STRICTLY CONFIDENTIAL Bio-Path Holdings, Inc.
Letter Agreement • November 22nd, 2019 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (108)
PLACEMENT AGENCY AGREEMENT
Placement Agency Agreement • February 17th, 2021 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York
Sample 1Sample 2Sample 3See All (91)
BIO-PATH HOLDINGS, INC. and EQUINITI TRUST COMPANY, LLC, as Warrant Agent Warrant Agency Agreement Dated as of August 7, 2023 WARRANT AGENCY AGREEMENT
Warrant Agency Agreement • August 7th, 2023 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York

WARRANT AGENCY AGREEMENT, dated as of August 7, 2023 (“Agreement”), between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and Equiniti Trust Company, LLC, a New York limited liability trust company (the “Warrant Agent”).

Sample 1Sample 2Sample 3See All (91)
Exhibit 10.3 Form SB-2 Ogden Golf Co. Corporation COMMERCIAL SECURITY AGREEMENT
Commercial Security Agreement • August 6th, 2003 • Ogden Golf Co Corp • Sporting & athletic goods, nec • Utah
Sample 1Sample 2Sample 3See All (67)
AT THE MARKET OFFERING AGREEMENT April 4, 2024
The Market Offering Agreement • April 4th, 2024 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York

Bio-Path Holdings, Inc., a corporation organized under the laws of Delaware (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:

Sample 1Sample 2Sample 3See All (33)
AutoNDA by SimpleDocs
PURCHASE AGREEMENT
Purchase Agreement • June 4th, 2010 • Bio-Path Holdings Inc • Retail-miscellaneous shopping goods stores • Utah

PURCHASE AGREEMENT (the “Agreement”), dated as of June 2, 2010, by and between BIO-PATH HOLDINGS, INC., a Utah corporation, (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).

Sample 1Sample 2Sample 3See All (6)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 22nd, 2019 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of January 18, 2019, between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Sample 1Sample 2Sample 3See All (5)
BIO-PATH HOLDINGS, INC. 2022 STOCK INCENTIVE PLAN RESTRICTED SHARE UNIT AWARD AGREEMENT
Restricted Share Unit Award Agreement • December 20th, 2022 • Bio-Path Holdings Inc • Pharmaceutical preparations • Delaware

This Restricted Share Unit Award Agreement (the “Agreement”) is made and entered into as of the award date set forth below (the “Award Date”) by and between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and the participant named below (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Company’s 2022 Stock Incentive Plan (the “Plan”).

Sample 1Sample 2Sample 3See All (5)
E-34
Ogden Golf Co Corp • May 8th, 2003 • Utah
Sample 1Sample 2Sample 3
BIO-PATH HOLDINGS, INC. 2022 STOCK INCENTIVE PLAN RESTRICTED SHARE AWARD AGREEMENT
Restricted Share Award Agreement • December 20th, 2022 • Bio-Path Holdings Inc • Pharmaceutical preparations • Delaware

This Restricted Share Award Agreement (the “Agreement”) is made and entered into as of the award date set forth below (the “Award Date”) by and between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and the participant named below (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Company's 2022 Stock Incentive Plan (the “Plan”).

Sample 1Sample 2Sample 3
STOCK APPRECIATION RIGHT AWARD AGREEMENT
Stock Appreciation Right Award Agreement • December 20th, 2022 • Bio-Path Holdings Inc • Pharmaceutical preparations • Delaware

This Stock Appreciation Right Award Agreement (the “Agreement”) is made and entered into as of the award date set forth below (the “Award Date”) by and between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and the participant named below (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Company’s 2022 Stock Incentive Plan (the “Plan”).

Sample 1Sample 2Sample 3
EMPLOYMENT AGREEMENT
Employment Agreement • February 19th, 2008 • Ogden Golf Co Corp • Retail-miscellaneous shopping goods stores • Utah

THIS EMPLOYMENT AGREEMENT (the “Agreement”), made this 1st ,day of May, 2007, between Douglas P. Morris (“Executive”) and BIO-PATH, Inc. (the “Company”).

Sample 1Sample 2
LEAK-OUT AGREEMENT
Leak-Out Agreement • November 6th, 2017 • Bio-Path Holdings Inc • Pharmaceutical preparations

This agreement (the “Leak-Out Agreement”) is being delivered to you in connection with an understanding by and among Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively, the “Holder”).

Sample 1Sample 2
Drug Product Development and Clinical Supply Agreement
Agreement • October 16th, 2008 • Bio-Path Holdings Inc • Retail-miscellaneous shopping goods stores • California

Bio-Path Holdings, Inc., a corporation organized and existing under the laws of the State of Utah, with its principal offices located at 3293 Harrison Blvd., Suite 230, Ogden, UT 84403 (hereinafter referred to as “CLIENT”).

Sample 1Sample 2
NON-QUALIFIED STOCK OPTION AWARD AGREEMENT
Non-Qualified Stock Option Exercise Agreement • December 20th, 2022 • Bio-Path Holdings Inc • Pharmaceutical preparations • Delaware

This Non-Qualified Stock Option Award Agreement (the “Agreement”) is made and entered into as of the award date set forth below (the “Award Date”) by and between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and the participant named below (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Company’s 2022 Stock Incentive Plan (the “Plan”).

Sample 1
AMENDMENT TO COMMON STOCK PURCHASE WARRANT
Common Stock Purchase Warrant • June 19th, 2017 • Bio-Path Holdings Inc • Pharmaceutical preparations

This Amendment to Common Stock Purchase Warrant (this “Amendment”) is dated as of June 13, 2017, by and between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”) and _____________________ (the “Holder”).

Sample 1
INCENTIVE STOCK OPTION AWARD AGREEMENT
Incentive Stock Option Award Agreement • December 27th, 2017 • Bio-Path Holdings Inc • Pharmaceutical preparations • Delaware

This Incentive Stock Option Award Agreement (the “Agreement”) is made and entered into as of the award date set forth below (the “Award Date”) by and between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and the participant named below (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Company’s 2017 Stock Incentive Plan (the “Plan”).

Sample 1
PATENT AND TECHNOLOGY LICENSE AGREEMENT
Patent and Technology License Agreement • May 15th, 2013 • Bio-Path Holdings Inc • Retail-miscellaneous shopping goods stores • Texas

This AGREEMENT ("AGREEMENT") is made oil this 2nd day of November, 2007, by and between THE BOARD OF REGENTS ("BOARD") of THE UNIVERSITY OF TEXAS SYSTEM ("SYSTEM"), an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701, on behalf of THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ("UTMDACC"), a component institution of SYSTEM, and BIO-PATH, INC. a corporation having a principal place of business located at 3293 Harrison Boulevard, Suite 230, Ogden, Utah 84403 ("LICENSEE").

Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.